Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm(TM) (dibutepinephrine) Sublingual Film
August 10, 2026
Pharmaceuticals
-
-
Jushi Holdings Provides Update on Plan of Arrangement
July 29, 2026
-
Lifecore Biomedical Signs Three New Customer Agreements
July 28, 2026
-
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
July 27, 2026
-
FLUENT Announces Definitive Agreement to Sell New York License and Certain Operations
July 23, 2026
-
Auxly Announces 14:1 Share Consolidation
July 22, 2026
-
Planet 13 Continues Strategic Florida Expansion with Upcoming Sarasota Store Opening
July 22, 2026
-
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
July 17, 2026
-
Mixie Technologies, Inc. (OTC: MIXE) Completes Corporate Rebranding and Trading Symbol Change
July 15, 2026
-
Glass House Brands Announces Uplist to NYSE
June 25, 2026
-
Chicago Atlantic Real Estate Finance, Inc. and Chicago Atlantic BDC, Inc. Announce Definitive Merger Agreement
June 18, 2026
-
Neurogene Announces Successful Completion of Dosing in Embolden(TM) Registrational Trial of NGN-401 for Rett Syndrome
June 8, 2026
-
Trulieve Announces Uplist to NYSE
June 5, 2026
-
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
-
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
June 1, 2026
-
Glass House Brands Completes Previously Announced Warrant Redemption
May 29, 2026